Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ATP, an attractive target for the treatment of refractory chronic cough
Mengru Zhang, Dominic L. Sykes, Laura R. Sadofsky, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 3, pp. 289-305
Open Access | Times Cited: 18

Showing 18 citing articles:

Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
Shota Yamamoto, Nobuyuki Horita, Johsuke Hara, et al.
CHEST Journal (2024) Vol. 166, Iss. 5, pp. 1124-1140
Closed Access | Times Cited: 4
Editorial—Translation of purinergic drugs into therapeutic use
Charles Kennedy
Purinergic Signalling (2025)
Closed Access
Unexplained or Refractory Chronic Cough in Adults
Richard S. Irwin, J. Mark Madison
New England Journal of Medicine (2025) Vol. 392, Iss. 12, pp. 1203-1214
Closed Access
Unmet needs and future directions of treatment options for chronic cough
Mengru Zhang, Alyn H. Morice
Expert Review of Respiratory Medicine (2025)
Closed Access
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study
Ignacio Dávila, Luís Puente‐Maestu, Santiago Quirce, et al.
Lung (2023) Vol. 201, Iss. 3, pp. 275-286
Open Access | Times Cited: 10
Mouth breathing, dry air, and low water permeation promote inflammation, and activate neural pathways, by osmotic stresses acting on airway lining mucus
David A. Edwards, Kian Fan Chung
QRB Discovery (2023) Vol. 4
Open Access | Times Cited: 8
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study
Mengru Zhang, Alyn H. Morice, Fengli Si, et al.
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 8
Neuroimmunology of the Lung
Rossana Azzoni, Olaf Perdijk, Nicola L. Harris, et al.
Annual Review of Immunology (2023) Vol. 42, Iss. 1, pp. 57-81
Closed Access | Times Cited: 7
Degranulation of human mast cells: modulation by P2 receptors’ agonists
Edward S. Schulman, Haruhisa Nishi, Amir Pelleg
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Decoding the Impact of the Placebo Response in Clinical Trials for Chronic Cough
Mengru Zhang, Bangyu Zhang, Alyn H. Morice
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00335-2024
Open Access | Times Cited: 1
Mucus Transpiration as the Basis for Chronic Cough and Cough Hypersensitivity
David A. Edwards, Kian Fan Chung
Lung (2023) Vol. 202, Iss. 1, pp. 17-24
Closed Access | Times Cited: 3
Purinergic P2X Receptors as Therapeutic Targets
Leanne Stokes, Stefan Bidula, Ronald Sluyter
Springer eBooks (2024), pp. 439-460
Closed Access
A Second Drug Binding Site in P2X3
Trung Thanh Thach, KanagaVijayan Dhanabalan, Prajwal P. Nandekar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The discovery and development of gefapixant as a novel antitussive therapy
Maria Gabriella Matera, Paola Rogliani, Clive P. Page, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1159-1172
Closed Access
Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S‐600918 and its analogue DDTPA
Dongping Wang, Meng Zhang, Ming Li, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1203-1220
Closed Access | Times Cited: 1
Decision: Mouth breathing, dry air, and low water permeation promote inflammation, and activate neural pathways, by osmotic stresses acting on airway lining mucus — R1/PR3
David A. Edwards, Kian Fan Chung
(2023)
Open Access
Decision: Mouth breathing, dry air, and low water permeation promote inflammation, and activate neural pathways, by osmotic stresses acting on airway lining mucus — R0/PR2
David A. Edwards, Kian Fan Chung
(2023)
Open Access
Camlipixant: A New Treatment Option for Refractory Chronic Cough?
Stephen K. Field
touchREVIEWS in Respiratory & Pulmonary Diseases (2023) Vol. 8, Iss. 2, pp. 2-2
Open Access
Review: Mouth breathing, dry air, and low water permeation promote inflammation, and activate neural pathways, by osmotic stresses acting on airway lining mucus — R0/PR1
David A. Edwards, Kian Fan Chung
(2022)
Open Access
Page 1

Scroll to top